Poorly controlled cholesterol is associated with cognitive impairment in T2DM: a resting-state fMRI study by unknown
Xia et al. Lipids in Health and Disease  (2015) 14:47 
DOI 10.1186/s12944-015-0046-xRESEARCH Open AccessPoorly controlled cholesterol is associated with
cognitive impairment in T2DM: a resting-state
fMRI study
Wenqing Xia1,2,3, Bin Zhang4, Yang Yang4, Pin Wang1, Yue Yang1 and Shaohua Wang1,2*Abstract
Background: Debate remains on whether hypercholesterolemia is associated with cognitive impairment. Hence,
we investigated whether poorly controlled cholesterol impairs functional connectivity among patients with type 2
diabetes mellitus (T2DM).
Methods: Resting-state functional connectivity infers to an interregional cooperation characterized by synchronous
and low-frequency (<0.08 Hz) fluctuations on blood oxygen level–dependent functional magnetic resonance
imaging (fMRI). We used resting-state fMRI to investigate the functional connectivity of 25 T2DM patients with
poorly controlled cholesterol, 22 patients with target cholesterol and 26 healthy controls. Further correlation
analysis was conducted between the functional connectivity and clinical data as well as neuropsychological tests.
Results: The three groups did not statistically differ in age, sex, education level, body mass index, blood pressure, fasting
C-peptides, and triglyceride. Compared with target cholesterol patients, patients with poorly controlled cholesterol
showed significantly increased levels of serum cholesterol, low-density lipoprotein (LDL), and LDL/high-density
lipoproteins (HDL) ratio, as well as poor performance in Trail Making Test B (TMT-B) (p < 0.05). Disordered functional
connectivity of bilateral hippocampus-middle frontal gyrus (MFG) in the poorly controlled group consistently existed
when compared with the two other groups. Moreover, the aberrant functional connectivity was associated with the
TMT-B scores and the LDL/HDL index in T2DM patients with poorly controlled cholesterol.
Conclusions: T2DM patients with poorly controlled cholesterol showed impaired attention and executive function. The
resting-state connectivity disturbance of the hippocampus-MFG may be involved in this process. Decreasing the LDL/HDL
ratio can be taken as precaution against cognitive decrements.
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Numerous publications support that type 2 diabetes melli-
tus (T2DM) patients have an increased risk of cognitive
impairment, especially learning and memory deficits [1,
2]. Diabetes mellitus (DM) is associated with a 1.5-fold to
2.0-fold increased risk of Alzheimer’s disease (AD), as well
as 2.0-fold to 2.5-fold increased risk of vascular dementia
[3]. In AD, the hippocampus is one of the primary brain
regions suffering damage, with early symptoms including* Correspondence: gyjwsh@126.com
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unless otherwise stated.memory loss and disorientation [4, 5]. Furthermore,
T2DM patients suffer from specific impairment in the
function and structure of the hippocampus [6–8].
Debate remains on whether hypercholesterolemia, which
often exists in T2DM patients, is etiologically associated
with cognitive impairment or dementia. Although prior re-
searches have failed to confirm that elevated cholesterol
brings a risk factor in developing AD [9, 10], most studies
found a positive relationship between elevated cholesterol
and cognitive impairment [11–13]. Various studies have
also focused on the relationship between cognition and
high-density lipoprotein (HDL) and low-density lipoprotein
(LDL) [14, 15]. To date, few studies on their effects on cog-
nitive impairment in T2DM patients reported conflictings is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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suggested that LDL level control was ineffective in reducing
cognitive decline among persons with poorly controlled
T2DM [16]. By contrast, two Asian research groups found
significant correlations between cognitive impairment and
abnormal levels of HDL and LDL in T2DM patients [17–
19]. However, all the above studies evaluated the cognitive
state of individuals by performing neuropsychological tests,
which can only provide some rough information on relevant
domains of cognition rather than specific brain areas. Thus,
the relationship between diabetes-related cognitive impair-
ment and abnormal cholesterol remains to be elucidated.
Traditional epidemiological studies have provided abun-
dant evidence regarding cognitive decline in T2DM patients.
As a complement to them, the resting-state functional mag-
netic resonance imaging (rs-fMRI) method is typically intro-
duced to investigate changes in the brain of T2DM patients.
Our previous work confirmed that T2DM patients show al-
tered amplitude of low-frequency fluctuations in many brain
regions, indicating that fMRI detects altered baseline brain
activity in patients with T2DM. Our work also concluded
that the abnormal alterations in the middle temporal gyrus
may play a central role in T2DM-related cognitive decline
[20]. Another fMRI study also observed that the hippocam-
pus displayed bilaterally decreased functional connectivity to
widespread regions in T2DM patients [21].
Resting-state functional connectivity infers to an inter-
regional cooperation, which can be characterized by syn-
chronous and low-frequency (<0.08 Hz) fluctuations on
blood oxygen level dependent fMRI [22]. To our know-
ledge, no research has focused on the influence of poor
cholesterol control on the cognitive function of diabetes
patients by using fMRI. Hence, the objective of this
study is to investigate whether increased cholesterol is
related to the decline in functional connectivity between
the bilateral hippocampus and other brain regions. And,
if so, we further examine whether this altered functional
connectivity is correlated with clinical information and
neurocognitive performance in T2DM patients.
Results and discussion
Clinical and neuropsychological data
Participant characteristics, clinical ratings, and cor-
rected neuropsychological scores are listed in Table 1.
The three groups did not statistically differ in age, sex,
education level, body mass index (BMI), blood pressure,
fasting C-peptides, triglyceride, intima-media thickness,
presence of WMH and lacunar infarcts. In terms of
neuropsychological tests, only Trail Making Test B
(TMT-B) (p < 0.05) showed significant differences in the
three groups. Overall, the poorly controlled cholesterol
group performed the worst. Compared with target choles-
terol patients, patients with poorly controlled cholesterol
showed significantly increased levels of serum cholesterol,LDL, and LDL/HDL index, as well as poor performance
in TMT-B (p < 0.05).
Functional connectivity data
A one-sample t-test revealed that the bilateral hippocampus
in all the groups demonstrated strong connectivity to other
brain regions, such as the anterior cingulate cortex, poster-
ior cingulate cortex, inferior parietal lobule (IPL), middle
frontal gyrus (MFG), middle temporal gyrus, and precu-
neus. The results were consistent with the default mode
network (DMN) proposed by Raichle et al. [23]. Similar
changes were also observed in several other regions, such
as the cerebellum posterior lobe, parahippocampal gyrus,
and occipital middle lobe (Fig. 1).
One-way ANOVA showed significant differences in the
functional connectivity of the left hippocampus among the
three groups; the regions included the left insula, left MFG,
bilateral IPL, bilateral calcarine, and left lingual gyrus. Sig-
nificant differences also exised in the right hippocampus
among the three groups; the regions included the left IFG,
right MFG, right IPL, bilateral calcarine, right lingual, and
right precuneus. Compared with healthy controls, patients
with poorly controlled cholesterol showed decreased func-
tional connectivity in the following brain regions: left insula,
left MFG and bilateral IPL. An increased connectivity was
observed in the bilateral calcarine and left lingual gyrus
(Fig.2a1 and Table 2). Furthermore, patients with poorly
controlled cholesterol showed decreased connectivity in the
left MFG and increased connectivity in the left lingual gyrus
compared with target cholesterol patients (Fig. 2a2 and
Table 2). Fig. 2b1 and Table 2 show the different connectivi-
ties in the right hippocampus. Patients with poorly con-
trolled cholesterol exhibited decreased connectivity in the
left IFG, right MFG, and right IPL. Patients with poorly con-
trolled cholesterol also demonstrated increased functional
connectivity in the bilateral calcarine and right lingual com-
pared with the healthy controls. Compared with the target
cholesterol group, the poorly controlled cholesterol group
showed decreased functional connectivity in the right MFG
and increased functional connectivity in the right precuneus
(Fig. 2b2 and Table 2).
Correlation analysis results
Patients with poorly controlled cholesterol showed sig-
nificant correlations between the clinical data (LDL/
HDL ratio, TMT-B scores, and waist-hip ratio (WHR))
and the functional connectivity of the left hippocampus-
left MFG (r = −0.607, p = 0.001; r = −0.442, p = 0.027;
r = −0.416, p = 0.039, respectively) (Fig. 3a), as well as
significant correlations between the clinical data (LDL/
HDL ratio and TMT-B scores) and the functional con-
nectivity of the right hippocampus-right MFG (r =
−0.418, p = 0.038; r = −0.552, p = 0.004, respectively)
(Fig. 3b). By contrast, no significant correlations existed
Table 1 Demographic, clinical, and cognitive characteristics
T2DM patients with
higher cholesterol (n = 25)
T2DM patients with





Age (year) 58.1 ± 8.1 57.7 ± 7.6 55.1 ± 6.5 0.293
Gender (male:female) 13:12 10:12 13:13 0.835
Education levels (years) 9.6 ± 3.8 10.8 ± 3.2 10.5 ± 2.6 0.443
Diabetes duration (years) 10.4 ± 5.8 9.4 ± 6.3 – 0.565
BMI (kg/m2) 24.6 ± 2.9 24.1 ± 2.6 23.8 ± 2.8 0.605
Waist-hip ratio 0.9 ± 0.1 0.9 ± 0.1 0.8 ± 0.1 0.4640.810
Systolic BP (mmHg) 133.6 ± 13.5 130.1 ± 12.5 127.5 ± 13.9 0.357
Diastolic BP (mmHg) 81.1 ± 8.8 80.7 ± 6.8 83.1 ± 8.4 0.627
HbA1c (%) 8.3 ± 1.7 7.2 ± 0.7 5.3 ± 0.3 <0.001*
Fasting glucose (mmol/L) 8.3 ± 2.2 7.4 ± 1.1 5.4 ± 0.3 <0.001*
Glucose after 2-h oral glucose tolerance test (mmol/l) 15.5 ± 5.4 14.0 ± 3.1 5.8 ± 1.0 <0.001*
Fasting C-peptide(ng/ml) 2.0 ± 1.0 1.5 ± 0.5 2.0 ± 0.9 0.135
Triglyceride (mg/dl) 159.4 ± 141.7 115.1 ± 106.3 124.0 ± 70.9 0.339
Total cholesterol (mg/dl) 224.3 ± 42.5a 166.3 ± 19.3 193.3 ± 19.3 <0.001*
LDL (mg/dl) 139.2 ± 23.2a 92.8 ± 11.6 112.1 ± 19.3 <0.001*
HDL (mg/dl) 54.1 ± 11.6 50.3 ± 11.6 54.1 ± 7.7 0.871
LDL/HDL index 2.8 ± 0.6 1.9 ± 0.5 2.1 ± 0.5 <0.001*
White matter hyperintensityb 0(0-5) 0(0-6) 0(0-4) 0.498
Lacunar infarcts (yes: no)c 5:20 4:18 4:22 0.913
Intima-mediathickness, mm 0.9 ± 0.2 1.0 ± 0.2 0.9 ± 0.2 0.359
MMSE 28.0 ± 0.3 28.7 ± 0.5 28.9 ± 0.6 0.350
MoCA 22.4 ± 0.8 23.1 ± 1.1 24.7 ± 1.3 0.421
AVLT 31.3 ± 2.1 27.5 ± 3.0 36.8 ± 3.6 0.092
CFT 34.7 ± 0.4 35.3 ± 0.6 34.4 ± 0.7 0.581
CFT- delayed recall 15.5 ± 1.4 14.6 ± 2.0 16.1 ± 2.4 0.873
TMT-A 71.2 ± 5.7 66.0 ± 8.0 64.2 ± 9.7 0.821
TMT-B 241.2 ± 17.2a 164.0 ± 24.2 131.9 ± 29.0 0.011*
CDT 3.2 ± 0.2 3.2 ± 0.2 3.3 ± 0.3 0.929
DST 10.6 ± 0.5 12.0 ± 0.8 13.0 ± 0.9 0.176
VFT 18.0 ± 1.1 19.3 ± 1.6 18.4 ± 1.9 0.810
* Indicated significant differences among the three groups (p <0.05)
a Indicated significant differences in clinical data and cognitive performances between T2DM patients with target cholesterol level and T2DM patients with poorly
controlled cholesterol (p <0.05)
b White matter hyperintensity were defined as ill-defined hyperintensities ≥ 5 mm on both T2 and FLAIR images
c Lacunar infarcts were defined as well-defined areas of > 2 mm with signal characteristics on MRI the same as cerebrospinal fluid
For TMT-A and B, a higher score corresponds to a poorer performance, whereas for the rest of the cognitive tests, a higher score corresponds to a
better performance
Abbreviations: LDL-C, low-density lipoprotein cholesterol; HDL-C, high-density lipoprotein cholesterol; MMSE, Mini Mental State Exam; MoCA, Montreal Cognitive
Assessment; AVLT, Auditory Verbal Learning test; CFT, Rey-Osterreith Complex Figure Test; TMT, Trail Making Test; CDT, Clock Drawing Test; DST, Digit Span Test;
VFT, Verbal fluency test
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tween right hippocampus and the right MFG.
Discussion
Implications of previous studies focusing on the relationship
between dyslipidemia and cognitive impairment remain
controversial. In the current study, fMRI methods were usedto provide initial support for the deleterious effect of ele-
vated cholesterol on attention and executive function of
T2DM patients. Correlation between the rs-fMRI informa-
tion and clinical data also suggested that functional connect-
ivity disturbance of the hippocampus-MFG may occupy an
important status in the cognitive dysfunction of T2DM
patients who failed to meet the cholesterol targets.
Fig. 1 Significant brain functional connectivity to the bilateral hippocampus using one-sample t-test: (a1) left hippocampal functional connectivity for healthy
controls; (a2) left hippocampal functional connectivity for T2DM patients with target cholesterol; (a3) left hippocampal functional connectivity for T2DM
patients with poorly controlled cholesterol; (b1) right hippocampal functional connectivity for healthy controls; (b2) right hippocampal functional connectivity
for T2DM patients with target cholesterol; and (b3) right hippocampal functional connectivity for T2DM patients with poorly controlled cholesterol. Thresholds
were set at a corrected p< 0.05, determined by Monte Carlo simulation. The left side corresponds to the right hemisphere of the brain
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were conducted to evaluate individual cognitive function.
Global cognitive function was evaluated using Mini
Mental State Exam (MMSE) and Montreal Cognitive As-
sessment (MoCA). MMSE is the most widely used test to
assess dementia, which focuses on five different cognitive
domains, namely, orientation, immediate memory, delayed
memory, attention/calculation, and linguistic capacity.
MoCA is developed as a brief screening instrument for
MCI and is more sensitive than MMSE. Memory decline
was revealed by Digit Span Test (DST), Auditory Verbal
Learning Test (AVLT), Verbal Fluency Test (VFT), and
Rey-Osterreith Complex Figure Test (CFT) -delay. CFT-
copy and Clock Drawing Test (CDT) assessed the domain
of visuoconstruction. Trail Making Test-A (TMT-A)
reflected the information-processing speed. However, all
the above tests showed insignificant differences amongFig. 2 Results of post-hoc analysis. (a1) For the left hippocampus, T2DM patients
the left insula, left MFG, and bilateral IPL and increased connectivity was seen in t
(a2) For the left hippocampus, T2DM patients with poorly controlled cholesterol
the left lingual gyrus when compared with T2DM patients with target cholestero
cholesterol had decreased connectivity in the left IFG, right MFG, and right IPL an
connectivity compared with the healthy controls; (b2) For the right hippocampu
connectivity in the right MFG and increased functional connectivity in the right p
set at a corrected p< 0.05, determined by Monte Carlo simulation. The left side cthe three groups. These results may partially be attributed
to the relatively younger ages and shorter disease dura-
tions. In addition, most neuropsychological tests cannot
detect subtle cognitive changes in such limited population.
Nevertheless, the diabetic patients, particularly the poorly
controlled group, showed slight decline of scores in most
of the tests. These changes revealed that patients with in-
creased cholesterol suffered cognitive decline in certain
aspects. Instructively, the TMT-B score in the poorly con-
trolled group showed significantly decreasing trends com-
pared with target cholesterol patients. In this study, the
deficits of attention and executive function defined by
TMT-B were the most prominent characteristics of the
T2DM patients with poorly controlled cholesterol. This
result specifically indicated that uncontrollable cholesterol
contributed overt damage to the attention and executive
function of T2DM patients.with poorly controlled cholesterol had decreased functional connectivity in
he bilateral calcarine and left lingual gyrus compared with healthy controls;
had decreased connectivity in the left MFG and increased connectivity in
l; (b1) For the right hippocampus, T2DM patients with poorly controlled
d their bilateral calcarine and right lingual had increased functional
s, the poorly controlled cholesterol group showed decreased functional
recuneus compared with the target cholesterol group. Thresholds were
orresponds to the right hemisphere of the brain
Table 2 Regions showing significant functional connectivity differences on hippocampus of T2DM patients group compared with
healthy controls
Brain regions BA MNI Coordinates x, y, z (mm) Peak t score Voxels
A.
Differences on left hippocampus
(I) T2DM patients with poorly controlled cholesterol versus with healthy controls
Decreased in T2DM patients with poorly controlled cholesterol
L insula 13 −33,9,6 −3.5398 131
L middle frontal gyrus 10 −36,57,18 −3.6381 291
L inferior parietal lobule 39/40 −39,-15,21 −3.9687 220
R inferior parietal lobule 39/40 45,-33,27 −4.0773 130
Increased in T2DM patients with poorly controlled cholesterol
L calcarine/ L lingual gyrus 17 −9,-57,9 4.3789 552
R calcarine 17 9,-96,-3 3.4545 124
(II) T2DM patients with poorly controlled cholesterol versus with T2DM patients with target cholesterol levels
Decreased in T2DM patients with poorly controlled cholesterol
L middle frontal gyrus 46 −27,42,21 −5.2780 195
Increased in T2DM patients with poorly controlled cholesterol
L lingual gyrus 17 −21,-51,-9 3.6838 85
B.
Differences on right hippocampus
(I) T2DM patients with poorly controlled cholesterol versus with healthy controls
Decreased in T2DM patients with poorly controlled cholesterol
L inferior frontal gyrus 44/45/46/47 −39,33,6 −4.2669 198
R middle frontal gyrus 46 36,33,9 −4.7610 1281
R inferior parietal lobule 40 45,-54,39 −4.5285 259
Increased in T2DM patients with poorly controlled cholesterol
R calcarine/ R lingual 17 9,-60,0 4.3660 256
L calcarine 17 −9,-57,6 3.9207 289
(II) T2DM patients with poorly controlled cholesterol versus with patients with target cholesterol levels
Decreased in T2DM patients with poorly controlled cholesterol
R middle frontal gyrus 46 36,39,27 −3.9874 267
Increased in T2DM patients with poorly controlled cholesterol
R precuneus 7 12,-63,21 3.4747 145
A corrected threshold of p < 0.05 determined by Monte Carlo simulation was taken as meaning that there was a significant difference between groups. BA,
Brodmann’s area; MNI: Montreal Neurological Institute; L, left; R, right; B = bilateral; cluster size is in mm3
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nectivity within the DMN in each group, which corre-
sponded well with the consensus that the DMN is involved
in maintaining baseline brain activities [23]. Similarly, a de-
cline in functional connectivity was observed in the DMN
of patients with poorly controlled cholesterol compared
with the control subjects. To some extent, the results were
in agreement with previous research [24]. The primary
finding of the present study indicated that the poorly con-
trolled group exhibited disrupted functional connectivity in
the MFG compared with target cholesterol patients. By
contrast, several distributed brain regions, including the
calcarine, lingual gyrus, and precuneus, showed enhancedfunctional connectivity, indicating that some compensatory
mechanisms may overcome the breakdown of communica-
tion in other brain areas. Among these selected brain re-
gions, the MFG has elicited considerable interest, for its
disordered functional connectivity in the poor controlled
group had been consistently shown when compared with
the two other groups. Coincidentally, as a commonly used
neuropsychological test that reflects frontal functioning,
TMT-B scores were paralleled with functional connectivity
measures in the MFG. These scores suggested that the de-
pressed functional connectivity, which implies the impaired
MFG function, may be vital in identifying the existence of
cholesterol-related cognitive dysfunction in T2DM patients.
Fig. 3 a Correlation between clinical data (low-density lipoproteins (LDL)/high-density lipoproteins (HDL) ratio, TMT-B scores, and waist-hip ratio
(WHR)) and the functional connectivity of the left hippocampus-left MFG. b Correlation between clinical data (LDL/HDL index, TMT-B scores, and
WHR) and the functional connectivity of the right hippocampus-right MFG
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correlations between the functional connectivity mea-
sures in the MFG of patients with poorly controlled
cholesterol and their clinical indices, including LDL/
HDL ratio and WHR. Abnormal lipid levels showed un-
doubtedly significant contribution to the risk of coronary
heart disease. Theoretically, dyslipidemia increases the
incidence rate of cerebrovascular disease, which is also
related to the risk of dementia [25]. High cholesterol
also plays a predominant role in the development of ath-
erosclerosis and coronary heart disease [26]. Thus, high
cholesterol level may be a modifiable risk factor for fu-
ture cognitive decline and dementia. In older adults, ath-
erosclerosis coincides with poorer attention and
executive function [27], a finding partially in line with
our results. The present study suggested that the LDL/
HDL ratio, as a strong predictor of cardiac events, may
be a predictive factor of cholesterol-related cognitive de-
cline in T2DM to a certain extent. Obesity, particularly
mid-life obesity, has been determined to be associated
with increased risk of cognitive impairment and demen-
tia [28]. Central adiposity estimated by higher WHRs is
associated with decreased cognitive function scores [29].
Previous studies have demonstrated that higher WHR,
which indicates critical resources for brain development,
are associated with poorer cognitive performance and
detrimental changes in the brain [30–33]. Similar to
LDL/HDL ratio, WHR is also a cardiovascular risk factor
in the elderly. However, this study failed to detect thecorrelation between functional connectivity of the right
hippocampus-MFG and WHR. We infer that computed
tomography and MRI scan should be further used to as-
sess visceral fat deposition, which significantly influences
on the WHR.
Certain limitations should be noted in the current
study. First, as a preliminary study, the cross-section
study showed a relatively small patient cohort. The num-
ber of participants in this study is based on the sample
size in previous literature. So far, most previous fMRI
studies on T2DM had small sample size, ranging from
10 to 30 subjects in each group [34–36]. Although based
on relatively small sample size, not only these previous
rs-fMRI studies but our study was able to obtained sig-
nificant findings. As fMRI results were obtained after
strict multiple comparison correction, which guaranteed
the credibility of these significant results, it implied that
the rs-fMRI is a sensitive tool for detecting the subtle
changes in brain activity and neural network. Neverthe-
less, the small sample size is still a major limitation,
leading to aberrant findings such as the low LDL level
this limited sample size may lead to low levels of LDL
in patients with well-regulated cholesterol and relatively
lower triglyceride level in all patients. In addition,
although we expected to focus on LDL, avoiding the po-
tential effects of other kinds of cholesterol (e.g., triglycer-
ide and HDL), was difficult because we cannot perform
further stratification based on the current population.
Thus, enlarging the sample size and following up on
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turbed functional connectivity in the hippocampus links
to the abnormal cholesterol level. Second, the average
cholesterol of the healthy controls was slightly higher than
that of the T2DM patients. This average can be ascribed
to the differences in the grouping criteria for cholesterol:
ADA for patients and normal range in our hospital for
healthy controls. Finally, multiple metabolic factors, such
as glucose and C-peptide, are involved in the development
of cognitive decline in T2DM. Although the two diabetic
groups showed similar clinical characteristics at baseline
because of the strict inclusion criteria, we added these
possible confounders as covariates to eliminate the inter-
ference to some extent, and more in-depth studies are re-
quired in this field to confirm the conclusions.
Conclusions
Despite of the limitations, our findings provide clinical im-
plications. Functional connectivity was used in the current
investigation to prove the effects of poorly controlled chol-
esterol on the attention and executive function of T2DM
patients. The results also proved that the resting-state con-
nectivity disturbance of the hippocampus-MFG may play a
significant role in the cognitive dysfunction of T2DM with
poorly controlled cholesterol levels. The cross-sectional
findings also provide information on the role of decreasing
LDL/HDL ratio to ameliorate the cognitive decrements.
Thus, the present findings offer some instructive informa-
tion regarding the intervention of cognitive decrements in
T2DM patients to some extent. Nevertheless, more com-
prehensive research, especially longitudinal studies, should
be performed to confirm these implications.
Methods
Subjects
A total of 80 right-handed subjects including 52 T2DM pa-
tients (aged between 45 and 70 years) and 28 healthy con-
trols were recruited via normal community health screening
and from a hospital from September 2012 to September
2013. T2DM diagnosis was based on the World Health
Organization (1999) criteria [37]. In accordance with the
lipid control goal of the American Diabetes Association
(ADA) [38], patients with LDL-C > 2.6 mmol/l or HDL-C <
1.0 mmol/l for men and < 1.3 mmol/l for women were
assigned to the poorly controlled cholesterol group (n = 27).
The rest was classified into the target cholesterol group (n =
25). No patients had consumed any cholesterol-lowering
drugs, owing to treatment cost and other reasons. Healthy
controls were recruited from the community during the
same period the study was conducted.
To eliminate the potential factor that may affect the re-
sults of this study, we excluded those patients with very
high glucose levels (fasting glucose > 10 mmol/l, postpran-
dial glucose > 20 mmol/l, HbA1c > 10 %). Participants wereexcluded from the study if they declared a history of known
stroke, alcoholism, head injury, Parkinson’s disease, epi-
lepsy, major depression, other acute neurological or psychi-
atric illnesses, major medical illnesses (e.g., cancer, anemia,
thyroid dysfunction, severe heart diseases and damaged
liver or kidney function), and severe visual or hearing loss.
The protocol and informed consent documents were
approved by the Research Ethics Committee of the Affili-
ated Zhongda Hospital of Southeast University. All partic-
ipants provided written informed consent prior to each
assessment.
Clinical data and neuropsychological test information
The study followed a cross-sectional design. Demographic
characteristics were obtained. Blood samples were col-
lected twice by venipuncture at 8 A.M. after an overnight
fast and 10 A.M. after drinking a 75 g glucose solution to
measure the levels of fasting blood glucose, fasting serum
C-peptide, HbA1c, triglyceride, total cholesterol, LDL-C,
HDL-C, and glucose after 2-h oral glucose tolerance test.
A battery of neuropsychological tests was adminis-
trated to all the subjects to evaluate individual neuro-
psychological status [21, 39]. MMSE was used to assess
possible dementia. MoCA was used to evaluate general
cognitive status. AVLT and CFT were used to reveal epi-
sodic memory. DST, TMT-A and TMT-B were used to
assess attention and psychomotor speed. CDT was used
to reflect visuospatial function, and VFT was used to
examine semantic memory. For TMT-A and TMT-B, a
higher score corresponds to a poorer performance,
whereas for the rest of the tests, a higher score corre-
sponds to a better performance. A neuropsychiatry spe-
cialist facilitated the process by using a single-blind
method. None of the participants displayed audiovisual
or motor coordination impairment that can affect the
neuropsychological tests.
Data acquisition
Subjects were scanned using a 3.0 T MRI scanner (Sie-
mens MAGENETOM Trio) with a birdcage head coil.
Subjects were laid supine with their head fixed by foam
pads and a belt to minimize head motion. Earplugs were
given to the subjects to reduce scanner noise. The subjects
were instructed to lie quietly with their eyes closed but
not to fall asleep, not to think of anything in particular,
and to avoid head motion during fMRI. All participants
underwent the scan at daytime with proper compliance.
Functional images were collected axially by using an
echo-planar imaging (EPI) sequence as follows: repeti-
tion time (TR) = 2000 ms, echo time (TE) = 25 ms,
slices = 36, thickness = 4 mm, gap = 0 mm, field of view
(FOV) = 240 × 240 mm2, acquisition matrix = 64 × 64,
and flip angle (FA) = 90°. High-resolution 3D T1-
weighted axial images covering the entire brain were
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TE = 2.48 ms, slices = 176, thickness = 1 mm, gap = 0 mm,
FA = 90°, acquisition matrix = 256 × 256, FOV = 250 ×
250 mm2. The entire process lasted for 12 min and 24 s.
On the basis of the age-related white matter changes
scale [40], the assessment of white matter hyperintensity
(WMH) and lacunar infarcts were quantitatively evaluated
on the fluid-attenuated inversion recovery images by expe-
rienced radiologists. A single-blind method was also used.
Participants with a rating score above one were excluded.Image preprocessing
Analyses were conducted with Data Processing Assistant
for rs-fMRI (DPARSF) programs [41], which are based on
statistical parametric mapping (SPM8, http://www.fil.io-
n.ucl.ac.uk/spm) and rs-fMRI data analysis toolkits (REST,
http://www.restfmri.net).
As described in our previous work [20], the first ten vol-
umes were discarded, considering the factors that signal
equilibrium of the initial MR signals and the adaptation of
the subjects to the circumstances. Then the remaining 230
consecutive volumes were used for data analysis. Subse-
quently, we performed the following in order: slice-timing
adjustment, realignment for head-motion correction, spatial
normalization to the Montreal Neurological Institute
(MNI) template (resampling voxel size = 3 × 3 × 3 mm3),
smoothing with an isotropic Gaussian kernel (FWHM=
4 mm), detrend and filtering (0.01–0.08 Hz).
We excluded the following from the study: one healthy
control with poor quality of image and seven participants
(two patients with higher cholesterol, three patients with
lower cholesterol, and two healthy controls) with head
movement exceeding 2.0 mm of maximum translation in
any of the x, y, and z directions or 2.0° of the maximum ro-
tation about the three axes. We further analyzed 25 patients
with higher cholesterol, 22 patients with lower cholesterol,
and 26 healthy controls.Functional connectivity
Functional connectivity analyses were performed using
REST software. The seed region of interests (ROIs) of the
bilateral hippocampus were generated using the WFU_
PickAtlas Tool v.2.4 software (http://www.ansir.wfubmc.
edu). For each subject, the mean time series for the ROIs
was calculated as the reference time course. Then, tem-
poral correlation analysis was performed between the
mean signal changes of ROI and time series of the
remaining brain areas. Finally, a Fisher’s r-to-z transform
was applied to improve normality of the correlation coeffi-
cients [42]. Six head motion parameters, the mean time
series of global white matter, and cerebrospinal fluid
signals were introduced as covariates to remove random
effects in the results.Statistical analysis
Demographic and clinical characteristics analysis
Differences in demographic information and clinic mea-
sures among groups were analyzed using ANOVA first
among the three groups followed by a post hoc test (t-
test for means and χ2-test for proportions) between
T2DM patients with target cholesterol and T2DM pa-
tients with uncontrolled cholesterol. A general linear
model was used to test for differences in neuropsycho-
logical test scores to control HbA1c and fasting glucose
levels to avoid a bias effect of these variables. Thresholds
were set at a corrected p < 0.05.
Functional connectivity analysis
One-sample t-test was performed on the individual func-
tional connectivity maps in a voxel-wise manner. The test
was used to determine the patterns of functional connectiv-
ity of regions with significant and positive connectivity to
the specific seed in each group. One-way analysis of variance
(ANOVA) was then performed to determine the functional
connectivity differences among the three groups. To explore
the between-group differences in functional connectivity,
post hoc analysis was further conducted by one-way
ANOVA, with age, sex, education, head motion, fasting C-
peptide, BMI, triglyceride, HbA1c, fasting and postprandial
glucose levels, intima-mediathickness, and presence of
WMH and lacunar infarcts importing as nuisance covariates
to control for the influences of these factors on the results.
Thresholds were all set at a corrected p < 0.05, with multiple
comparison correction using AlphaSim program (http://afni.
nimh.nih.gov/pub/dist/doc/manual/AlphaSim.pdf) and de-
termined by Monte Carlo simulation. The parameters were
single voxel p value = 0.05, a minimum cluster size of 85 mm3,
and FWHM=4 mm within a gray matter mask corre-
sponding to Automated Analytical Labeling AAL atlas [43].
Correlation analysis
The mean z-values were extracted to investigate the associ-
ation between functional connectivity of hippocampus-MFG
and clinical data and neurocognitive performances of T2DM
patients with higher cholesterol. Then, the Pearson’s correl-
ation coefficients between the clinical data, results of each
neuropsychiatric test and the individual z-values in patients
with higher cholesterol group were analyzed by SPSS soft-
ware (version 17.0). A value of p < 0.05 was considered sta-
tistically significant. The correlations were also corrected for
age, sex and other possible confounders mentioned before.
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